Amarantus Bioscience Holdings Inc (AMBS)

[Riskreturn168]

Yes, it is curious that after we get validation from two separate independent researchers, Urano & Saarma, that MANF successfully treats and halts the effects of Diabetes, that our stock would go down!! That is perplexing.

One thought is the Bio Sector is down 30 to 50% and many of the core shareholders with AMBS have other bio stocks getting margin calls. So perhaps they are forced to sell some AMBS shares to cover their margin calls.

And, we are being manipulated, for whatever motive.

We are going to need a partnership on something to catapult us up to .20 cents. That, or fantastic news on 3 or 4 fronts. I think we'll do it, the question is when?